Brief: Diaxonhit grants Felicitex global exclusive license

Eurobio Scientific SA

19/05/2015 06:31

May 19 (Reuters) - Diaxonhit SA  ALEHT.PA : 
    * Grants Felicitex a global exclusive license of a series of 
lead-stage anti-cancer compounds against quiescent cancer cells 
    * Felicitex has paid an up-front fee and is responsible for 
annual licensing payments 
    * Felicitex to pay future milestone payments as product 
covered by licensing agreement reaches specific development 
milestones and royalty payments if and when product is marketed 
 
Source text for Eikon:  ID:nHUG7kHzQr  
Further company coverage:  ALEHT.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 6983920;))